Boxer Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-750,000
| Closed | -$7.04M | – | 21 |
|
|
2024
Q3 | $7.04M | Hold |
750,000
| – | – | 0.35% | 46 |
|
|
2024
Q2 | $6.02M | Hold |
750,000
| – | – | 0.32% | 48 |
|
|
2024
Q1 | $11.1M | Sell |
750,000
-650,000
| -46% | -$9.63M | 0.55% | 42 |
|
|
2023
Q4 | $11.4M | Sell |
1,400,000
-2,305,133
| -62% | -$18.7M | 0.57% | 32 |
|
|
2023
Q3 | $16.9M | Hold |
3,705,133
| – | – | 0.9% | 34 |
|
|
2023
Q2 | $26.1M | Hold |
3,705,133
| – | – | 1.21% | 30 |
|
|
2023
Q1 | $22.6M | Buy |
3,705,133
+2,200,000
| +146% | +$13.4M | 1.11% | 30 |
|
|
2022
Q4 | $9.62M | Sell |
1,505,133
-430,000
| -22% | -$2.75M | 0.51% | 43 |
|
|
2022
Q3 | $18.5M | Hold |
1,935,133
| – | – | 1.04% | 34 |
|
|
2022
Q2 | $21.4M | Hold |
1,935,133
| – | – | 1.35% | 26 |
|
|
2022
Q1 | $32.2M | Buy |
1,935,133
+835,133
| +76% | +$13.9M | 1.66% | 19 |
|
|
2021
Q4 | $21M | Hold |
1,100,000
| – | – | 0.82% | 29 |
|
|
2021
Q3 | $27.1M | Buy |
+1,100,000
| New | +$27.1M | 0.95% | 32 |
|
|
2020
Q3 | – | Sell |
-200,000
| Closed | -$5.49M | – | 76 |
|
|
2020
Q2 | $5.49M | Buy |
+200,000
| New | +$5.49M | 0.24% | 57 |
|